Epidemioclinical profile and management of post thrombotic syndrome in Antananarivo
Introduction: The post-thrombotic syndrome (PTS) is the most complication of deep vein thrombosis who deserves an early management. The aim of this study was to determine the epidemio-clinical profile and the management of PTS.
Methods: This was a retrospective and descriptive study for a period of 6 years from January 2013 to December 2018, performed at the Cardiovascular Surgery Unit in JRA Teaching Hospital Antananarivo, including all patients who presented post-thrombotic syndrome after an acute episode of deep venous thrombosis.
Results: 106 patients were recorded among 315 patients who presented an episode of DVT (33.65%) and 14110 patients admitted in this period (0.75%). The average age was 46.18 years old. There were 30 males (28.30%) and 76 female (71.69%). The most important risk factors of PTS were previous history of varicose veins (50%), sedentary lifestyle (45.28%), insufficiency of anticoagulant therapy (68.86%) and proximal DVT (47.16%). Delayed of diagnosis were greater than or equal to 2 years after an acute DVT in 86 patients (81.13%). The most clinical signs were edema (56.60%) and varicose veins (54.71%). According the Villalta’s score, PTS were mild in 48 patients (45.28%), moderate in 47 patients (44.33%) and severe in 11 patients (10.37%). Management was lifestyles change (45.28%), compression stockings (100%), anticoagulant therapy (100%) and surgical treatment (65.09%).
Conclusion: The frequency of PTS was 33.65% in our study. PTS reduces quality of life of patients, but it can be avoided if the treatments of DVT are adapted.
Keywords: Deep vein thrombosis, Post-thrombotic syndrome, Epidemiology, Management
2. Galanaud, JP, Monreal M, Kahn SR. Epidemiology of the post-thrombotic syndrome. Thrombosis research 2018; 164:100-109.
3. Ashrani AA, Heit JA. Incidence and cost burden of post-thrombotic syndrome. Journal of thrombosis and thrombolysis 2009; 28(4):465-476.
4. Ma H, O'Donnell Jr TF, Rosen NA, Iafrati MD. The real cost of treating venous ulcers in a contemporary vascular practice. Journal of Vascular Surgery: Venous and Lymphatic Disorders 2014; 2(4):355-361.
5. Bergan JJ, Schmid-Schönbein GW, Smith PDC, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. New England Journal of Medicine 2006; 355(5):488-498.
6. Kayssi A, Roche-Nagle G. Postthrombotic syndrome. CMAJ 2014; 186(1):62-62.
7. Nishimoto Y, Yamashita Y, Morimoto T, Saga S, Amano H, Takase T et al. Risk factors for post-thrombotic syndrome in patients with deep vein thrombosis: from the COMMAND VTE registry. Heart and vessels 2019; 34(4):669-677.
8. Ondze-Kafata LI, Kouala Landa C, Traore-Kissima A, Loumouamou M, Bani M, Amounya-Zobo S. La thrombose veineuse des membres inférieurs à brazzaville: à propos de 44 cas. Cardiologie Tropicale 2012; 135:1-11.
9. Saleh MI, Atalla KA, Taha AG, Sayed AK. Short-term patency of catheter-directed thrombolysis for iliofemoral deep vein thrombosis. The Egyptian Journal of Surgery 2018; 37(3):309-315.
10. Huang H, Gu JP, Shi HF, Shi WY, Lu JY, Chen L et al. Assessment of the probability of post-thrombotic syndrome in patients with lower extremity deep venous thrombosis. Scientific reports 2018; 8(1):1-7.
11. Kahn SR. The post-thrombotic syndrome. Hematology Am Soc Hematol Educ Program. 2016; 2016(1):413-418.
12. Kahn SR, Shrier I, Shapiro S, Houweling AH, Hirsch AM, Reid RD et al. Six-month exercise training program to treat post-thrombotic syndrome: a randomized controlled two-centre trial. Cmaj 2011; 183(1):37-44.
13. Delluc A, Gouedard C, De LSM, Garcia C, Roguedas AM, Bressollette L et al. Incidence, facteurs de risque et signes cutanés de la maladie post-thrombotique : suivi à quatre ans des patients inclus dans l’étude EDITH. La Revue de médecine interne 2010; 31(11):729-734.
14. Mant MJ, Eurich DT, Russell DB, Majumdar SR. Post-thrombotic syndrome after total hip arthroplasty is uncommon. Acta orthopaedica 2008; 79(6):794-799.
15. Tick LW, Kramer MH, Rosendaal FR, Faber WR, Doggen CJM. Risk factors for post‐thrombotic syndrome in patients with a first deep venous thrombosis. Journal of Thrombosis and Haemostasis 2008; 6(12):2075-2081.
16. Kahn SR, Shrier I, Julian JA, Ducruet T, Arsenault L, Miron MJ et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Annals of internal medicine 2008;149(10):698-707.
17. Alshoabi SA, Mothanna A. Deep Venous Thrombosis: Commonly Affected Veins in the Lower Limbs. Journal of Biosciences and Medicines 2019; 7(3):12-19.
18. Zhang Z, Song K, Yao Y, Jiang T, Pan P, Jiang Q. Incidence and risk factors for post-thrombotic syndrome in patients with deep vein thrombosis following total knee and hip arthroplasty. The Journal of arthroplasty 2019; 34(3):560-563.
19. Kahn SR, Comerota AJ, Cushman M, et al; American Heart Association Council on Peripheral Vascular Disease, Council on Clinical Cardiology, and Council on Cardiovascular and Stroke Nursing. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2014; 130(18):1636-1661
20. Schulman S, Lindmarker P, Holmstro¨mM, Lärfars G, Carlsson A, Nicol P et al. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost 2006; 4:734-42.
21. Soosainathan A, Moore HM, Gohel MS, Davies AH. Scoring systems for the post-thrombotic syndrome. Journal of vascular surgery 2013; 57(1):254-261.
22. Sharathkumar AA, Pipe SW. Post-thrombotic syndrome in children: a single center experience. Journal of Pediatric Hematology/Oncology 2008; 30(4):261-266.
23. Biguzzi E, Mozzi E, Alatri A, Taioli E, Moia M, Mannucci PM. The post-thrombotic syndrome in young women: retrospective evaluation of prognostic factors. Thromb Haemost. 1998; 80(4):575-577.
24. Bittar LF, Silva LQD, Orsi FLDA, Zapponi KCS, Mazetto BDM, Paula EVD. Increased inflammation and endothelial markers in patients with late severe post-thrombotic syndrome. Plos one 2020; 15(1):e0227150.
25. Stain M, Schönauer V, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Kyrle PA, Eichinger S. The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease. J Thromb Haemost 2005; 3:2671-6.
26. Rabinovich A, Ducruet T, Kahn SR, SOX Trial Investigators, Shapiro S, Tagalakis V et al. Development of a clinical prediction model for the postthrombotic syndrome in a prospective cohort of patients with proximal deep vein thrombosis. Journal of Thrombosis and Haemostasis 2018; 16(2):262-270.
27. Baekgaard N. Incidence and location of deep vein thrombosis in the lower extremities: what do we know. Phlebolymphology 2017; 24(2):97-104.
28. Brinegar KN, Sheth RA, Khademhosseini A, Bautista J, Oklu R. Iliac vein compression syndrome: clinical, imaging and pathologic findings. World journal of radiology 2015; 7(11):375-381.
29. Avila ML, Pullenayegum E, Williams S, Yue N, Krol P, Brandão LR. Postthrombotic syndrome and other outcomes of lower extremity deep vein thrombosis in children. Blood 2016; 128(14):1862-1869.
30. Pichot O, Menez C. Role of duplex ultrasound investigation in the management of postthrombotic syndrome. Phlebolymphology 2016; 23(2):102-111.
31. Kahn SR, Galanaud JP, Vedantham S, Ginsberg JS. Guidance for the prevention and treatment of the post-thrombotic syndrome. Journal of thrombosis and thrombolysis, 2016; 41(1):144-153.
32. Makedonov I, Kahn SR, Galanaud, JP. Prevention and Management of the Post-Thrombotic Syndrome. J Clin Med 2020; 9(4), 923.
33. Rabinovich A, Kahn SR. How I treat the postthrombotic syndrome. Blood 2018; 131(20):2215-2222.
34. Ten Cate Hoek AJ. Prevention and treatment of the post thrombotic syndrome. Research and practice in thrombosis and haemostasis 2018; 2(2), 209-219.
35. Azirar S, Appelen D, Prins MH, Neumann MH, de Feiter AN, Kolbach DN. Compression therapy for treating post‐thrombotic syndrome. Cochrane Database of Systematic Reviews 2019; (9).
36. Yamaki T. Post-thrombotic syndrome–Recent aspects of prevention, diagnosis and clinical management. Reviews in Vascular Medicine 2016; 6:10-19.
37. Burgstaller JM, Steurer J, Held U, Amann-Vesti B. Efficacy of compression stockings in preventing post-thrombotic syndrome in patients with deep venous thrombosis: a systematic review and metaanalysis. Vasa. 2016; 45(2):141-7.
38. Schulman S, Lindmarker P, Holmstrom M, Larfars G, Carlsson A, Nicol P et al. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost 2006; 4:734-742.
39. Khanna AK, Singh S. Postthrombotic syndrome: surgical possibilities. Thrombosis 2012; 2012.
40. Rai R. Standard guidelines for management of venous leg ulcer. Indian Dermatol Online J 2014; 5(3):408-41.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).